Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.
about
The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: phase II trial.Targeted therapies for gastric cancer: current status.A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers.Recent advances in chemotherapy for advanced gastric cancerRefining docetaxel-containing therapy for gastric cancer.Review of docetaxel in the treatment of gastric cancer.Targeted therapy for gastric cancer--current status.A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer.A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer.
P2860
Q33405235-04B50F9A-6668-4771-869B-88BDE364C00BQ34205672-F78B512B-0D0C-4AE9-8AFB-7C37A32D9D60Q34307924-CAB407F6-D473-4588-8168-15E3CE7AAC22Q34389753-D961F894-3BFB-4D1D-AF42-F424338E40A2Q35445166-C6F6DDC9-4E3C-44DC-8AAE-3D6A8661A083Q37052880-214E86E4-15CE-498D-87E5-3B77D8F293ADQ38019898-EEF227F2-8B1B-416C-820D-21D8CD50746EQ51028375-C76DA585-EBDC-4D39-9E82-B68B51AF3BFEQ54239648-7F4A5B74-C823-4C49-AFA8-30B25EA3E855Q54645262-42567188-4C79-4B00-B8D4-0CC889504BCB
P2860
Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Multicenter phase II study of ...... aegu Gyeongbuk Oncology Group.
@ast
Multicenter phase II study of ...... aegu Gyeongbuk Oncology Group.
@en
type
label
Multicenter phase II study of ...... aegu Gyeongbuk Oncology Group.
@ast
Multicenter phase II study of ...... aegu Gyeongbuk Oncology Group.
@en
prefLabel
Multicenter phase II study of ...... aegu Gyeongbuk Oncology Group.
@ast
Multicenter phase II study of ...... aegu Gyeongbuk Oncology Group.
@en
P2093
P2860
P356
P1476
Multicenter phase II study of ...... aegu Gyeongbuk Oncology Group.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604188
P407
P577
2008-01-22T00:00:00Z